These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3937262)

  • 1. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial reconstitution of factor VIII activity from a mild Crm+ hemophilia A patient by replacement of the defective A2 domain.
    Pieneman WC; Fay P; Briët E; Reitsma PH; Bertina RM
    Thromb Haemost; 1998 May; 79(5):943-8. PubMed ID: 9609226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
    Wagenvoord R; Hendrix H; Soria C; Hemker HC
    Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
    van Dieijen G; Tans G; Rosing J; Hemker HC
    J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa.
    McGee MP; Li LC; Hensler M
    J Exp Med; 1992 Jul; 176(1):27-35. PubMed ID: 1613461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.
    Neuenschwander P; Jesty J
    Blood; 1988 Nov; 72(5):1761-70. PubMed ID: 3140913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ; Pemberton S; Acquila M; Mori PG; Tuddenham EG; O'Brien DP
    Thromb Haemost; 1994 Apr; 71(4):428-33. PubMed ID: 8052958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of human factor IXa activity in an isolated factor X activation system.
    Griffith MJ; Reisner HM; Lundblad RL; Roberts HR
    Thromb Res; 1982 Aug; 27(3):289-301. PubMed ID: 6814005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathway of coagulation on endothelial cells.
    Nawroth PP; Stern DM
    J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium.
    Lupu F; Moldovan N; Ryan J; Stern D; Simionescu N
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):743-52. PubMed ID: 8292724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
    Link RP; Castellino FJ
    Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies of the activation of factor X by factors IXa and VIII:C in the absence of thrombin.
    Neal GG; Esnouf MP
    Br J Haematol; 1984 May; 57(1):123-31. PubMed ID: 6426496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.